A
Arnold J. Levine
Researcher at Institute for Advanced Study
Publications - 493
Citations - 122094
Arnold J. Levine is an academic researcher from Institute for Advanced Study. The author has contributed to research in topics: Gene & Mutant. The author has an hindex of 139, co-authored 485 publications receiving 116005 citations. Previous affiliations of Arnold J. Levine include Harvard University & Affymetrix.
Papers
More filters
Journal ArticleDOI
Spontaneous and inherited TP53 genetic alterations
TL;DR: The p53 protein is a transcription factor that prevents tumors from developing as discussed by the authors, however, mutations in the DNA binding domain of the TP53 gene contribute to tumor formation and can produce a wide distribution in the transcriptional capabilities of the mutant p53 proteins with over four logs differences in the efficiencies of forming cancers in many diverse tissue types.
Journal ArticleDOI
The Genetic Origins of Neoplasia
TL;DR: The last 15 years have witnessed a conceptual breakthrough in understanding of the molecular and genetic basis of the origins of neoplasia in humans, methodically, experiment by experiment, with no one observation yielding the entire picture.
Journal ArticleDOI
The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway.
TL;DR: This data indicates that a high-expression of IGF-1 in the blood of patients with parkinson disease is a potential biomarker of Parkinson's disease and the use of RHEB to correct for this problem is warranted.
Journal ArticleDOI
DNA replication in SV40-infected cells. VI. The effect of cycloheximide on the formation of SV40 oligomeric DNA.
Rudolf Jaenisch,Arnold J. Levine +1 more
TL;DR: Viral DNA synthesized prior to the addition of cycloheximide did not participate, or participated to only a small extent, in the formation of SV40 oligomeric DNA observed after cyclo heximide treatment, and the available evidence indicates that SV 40 oligomers were synthesized by the replication of viral DNA in the absence of protein synthesis.
Journal ArticleDOI
Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice.
TL;DR: These studies show that transgenic mice expressing SV40 T antigen are capable of responding to determinants not shared between JCV and SV 40 T antigen.